TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
陳瓊美CHEN, CHIUNG-MEI
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
-
cmchen@cgmh.org.tw
發表文獻
28筆
1
Wu YR, Chang KH, Chao CY, Lin CH, Chen YC, Liu TW, Lee-Chen GJ, Chen CM*. Association of SOD2 p.V16A polymorphism with Parkinson's disease: A meta-analysis in Han Chinese. J Formos Med Assoc. 2021 Jan;120(1 Pt 2):501-507.
2
Chen CM, Yen CY, Chen WL, Lin CH, Wu YR, Chang KH, Lee-Chen GJ. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation. Int J Mol Sci. 2021 Jan 21;22(3):1062.
3
Chien CY, Chang KH, Chen CM*. X-linked adrenoleukodystrophy caused by a novel mutation presenting with various phenotypes in a Taiwanese family. Clin Chim Acta. 2021 Mar;514:100-106.
4
Chiang HL, Wu YR, Chen YC, Fung HC, Chen CM*. Fibroblast Growth Factor 20 Gene Polymorphism in Parkinson's Disease in Asian Population: A Meta-Analysis. Genes (Basel). 2021 Apr 29;12(5):674.
5
Liu T-W, Wu Y-R, Chen Y-C, Fung H-C, Chen CM*.. Polymorphisms of Interleukin-6 and Interleukin-8 Are Not Associated with Parkinson’s Disease in Taiwan. Brain Sciences. 2021; 11(6):768.
6
Oh SL, Chen CM, Wu YR, Valdes Hernandez M, Tsai CC, Cheng JS, Chen YL, Wu YM, Lin YC, Wang JJ. Fixel-Based Analysis Effectively Identifies White Matter Tract Degeneration in Huntington's Disease. Front Neurosci. 2021 Sep 13;15:711651. (co-first author)
7
Mandala SHS, Liu TJ, Chen CM, Liu KK, Januar M, Chang YF, Lai CS, Chang KH, Liu KC. Enhanced Plasmonic Biosensor Utilizing Paired Antibody and Label-Free Fe3O4 Nanoparticles for Highly Sensitive and Selective Detection of Parkinson's α-Synuclein in Serum. Biosensors (Basel). 2021 Oct 18;11(10):402.
8
Huang CC, Chang KH, Chiu YJ, Chen YR, Lung TH, Hsieh-Li HM, Su MT, Sun YC, Chen CM*, Lin W, Lee-Chen GJ. Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity. Cells. 2021 Nov 9;10(11):3095. doi: 10.3390/cells10113095.
9
Chiu YJ, Lin TH, Chen CM, Lin CH, Teng YS, Lin CY, Sun YC, Hsieh-Li HM, Su MT, Lee-Chen GJ, Lin W, Chang KH. Novel Synthetic Coumarin-Chalcone Derivative (E)-3-(3-(4-(Dimethylamino)Phenyl)Acryloyl)-4-Hydroxy-2H-Chromen-2-One Activates CREB-Mediated Neuroprotection in Aβ and Tau Cell Models of Alzheimer's Disease. Oxid Med Cell Longev. 2021 Nov 13;2021:3058861. (co-first author)
10
Wu HC, Chang KH, Chiang MC, Chen CM*. Alterations of Plasma Galectin-3 and C3 Levels in Patients with Parkinson's Disease. Brain Sci. 2021 Nov 15;11(11):1515.
